Loading...
BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia
[Image: see text] The therapeutic treatment of negative symptoms and cognitive dysfunction associated with schizophrenia is a significant unmet medical need. Preclinical literature indicates that α7 neuronal nicotinic acetylcholine (nACh) receptor agonists may provide an effective approach to treati...
Na minha lista:
| Udgivet i: | ACS Med Chem Lett |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Chemical
Society
2017
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5346989/ https://ncbi.nlm.nih.gov/pubmed/28337332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.7b00032 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|